Promoter buys 60,000 shares (0.62%) of Goldline Pharma via open market

Promoter Stake BuyPromoter Below 50pctOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.5%1-day move

₹44.75

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-3.5-3.8-4.2-5.5-5.6-6.0-12.7-10.6——

Up moveDown movePending

AI summary

Mr. Swapan Khandelwal, Promoter and Whole Time Director of Goldline Pharmaceutical, acquired 60,000 equity shares (0.62%) through open market on 22 June 2026. His holding rose from 28.65% to 29.27% (28,09,988 shares) of paid-up capital. Disclosed under SEBI SAST Regulation 29(2).

Likely market impact

Signals promoter confidence. Small uptick in promoter stake; supports long-term alignment with minority shareholders.